Position in ABBV
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$2,326,728,674
-$61,084,586 QoQ
Shares Held
10,698,095
+2.4% QoQ
Ownership
0.606%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 99.95927312292515.ToString("F0")%
Shared 0.040726877074843695.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Amundi holds $19,301,385,364 across 13 Drug Manufacturers - General names. ABBV ranks #4 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,055,025 | $4,649,460,337 | |
| 2 | JNJ |
Johnson & Johnson
|
13,406,820 | $3,277,163,076 | |
| 3 | AZN |
Astrazeneca PLC
|
15,386,149 | $3,034,456,300 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
10,698,095 | $2,326,728,674 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,764,954 | $1,655,786,310 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,539,111 | $1,468,835,897 | |
| 7 | AMGN |
Amgen Inc
|
3,377,306 | $1,188,305,111 | |
| 8 | PFE |
Pfizer Inc
|
40,825,470 | $1,146,379,191 |
All Filings in ABBV
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,326,728,674 | 10,698,095 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $2,387,813,260 | 10,450,406 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,433,095,713 | 10,508,317 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,687,971,846 | 9,093,696 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,395,052,028 | 6,658,324 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,483,314,487 | 8,347,296 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,506,751,254 | 7,629,893 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,219,425,201 | 7,109,522 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,147,543,746 | 6,301,723 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,236,958,904 | 7,981,925 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,224,876,536 | 8,217,339 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,220,075,793 | 9,055,710 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,378,902,216 | 8,652,207 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $995,083,340 | 6,157,313 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $692,433,668 | 5,159,330 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $843,342,136 | 5,506,282 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $765,678,910 | 4,723,206 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $708,051,676 | 5,229,333 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $627,471,586 | 5,816,924 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $515,976,452 | 4,580,757 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||